Ahjay it appears this abstract is in fact a methods plan moving forward in TACTI 002 ,with ,Merck,not a Novartis expansion trial as touted by some US investors?
ASCO abstracts, page-3
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
-0.005(1.47%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.5¢ | $435.3K | 1.309M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 227388 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 63534 | 5 |
View Market Depth
| Last trade - 13.21pm 30/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |